MedTech Strategist, the global medical device industry's most trusted resource, will help you stay ahead of the opportunities and obstacles that are impacting your corporate strategy. We invite you to explore our coverage. Think Strategically. Subscribe Today
Browse Latest Issue
Coronary microvascular disease can contribute to major cardiovascular pathology, but there are no approved disease-modifying therapies. On the hunt for a new solution, VahatiCor is pursuing a new device that narrows coronary sinus flow to improve perfusion in the microvascular network.
An Israel-based start-up is taking on a cellular-level challenge that is somehow both elusive and ubiquitous at the same time.
An Israel-based start-up is taking on a cellular-level challenge that is somehow both elusive and ubiquitous at the same time.